灵麦药业不足公司携手并肩Venture Valuation邀请您报名参加历时一天的生物技术产品与公司评估的讨论会了解生物医药领域普遍应用的估值的定义和方式 掌握怎样评估和测算生物技术公司的使用价值学习培训怎样评估在研药物的使用价值及其怎样去交涉产品的受权买卖时间: 2020年5月5日 周二 8:30 - 17:00 地址: 万豪大酒店，中国上海 花费:vip会员公司: 14,000 RMB/人非会员公司: 15,000 RMB/人*左右价钱未税 注：2020年1月25此前报考可获12,000RMB/人早鸟价讨论会最多容下20位外宾来访根据课程内容，你可以学习培训：掌握决策生命科学领域生物技术产品和制药业公司估值的要素全方位把握和了解重要评估条文，定义，专用工具和方式 学习培训并训练：a) 怎样在估值以前用实体模型去评估生物技术公司的非各种因素b) 怎样运用一款能够带回去的Excel专用工具测算在研化学物质的使用价值并将其运用于别的一切一在研药品产品c) 怎样机构药品生产企业与生物科技公司中间的专利权受权买卖，包含怎样明确分阶段的支付方式及专利年费用从Patrik Frei那边获得权威专家聚焦点和具体指导，Patrik Frei早已在生命科学领域评估了很多的产品和公司与我国各大药业领域公司BD单位权威专家有近距沟通交流，共享感受与工作经验培训讲师—Patrik Frei:Patrik是欧州顶级的髙速成长性生命科学公司的估值权威专家；Patrik是Venture Valuation AG公司的创办人和ceo，善于在生物技术和生命科学领域中开展单独点评和兴盛高成长性公司的估值；Patrik和他的精英团队曾一起协助诺华基金投资执行了全部的外界估值；他都是全世界生命科学数据库查询—博谷（Biotechgate）的开发人员行程安排08:30 每日签到09:00 大会刚开始并致词09:15估值的实际详细介绍课程内容的简述估值的基本知识估值的关键用意：考量风险性与重归10:00怎样在估值以前评估一家公司为什么在开展估值以前先掌握一家公司是十分关键的三大关键步骤：管理方法-技术性-销售市场评估一家公司的20个必需要素10:30 歇息10:45公司估值,互动交流阶段：概述对生命科学药业公司估值的方式（例：标价）和为什么简易的方式 却能更合理重中之重解读一些早已实践活动过的估值方法：a) 现金流量打折b) 公司资产方法c) 销售市场/买卖较为估值的操作过程 – 案例讨论小组合作实践活动阶段：外宾来访将会被排序，在获得一个实例时，每一工作组将还有机会来评估一个生命科学公司。接着向别的工作组展现并相互之间探讨其估值結果12:30 午饭13:45产品估值与买卖构造,互动交流阶段：公司与产品估值的不一样哪些的信息内容就是你所必须的 – 怎样去获得所必须的信息内容？概述产品估值方法深层次论述在制药业与生物科技领域常见的方式 ：风险性调节净现值（rNPV）怎样从各种各样产品的估值中评估这个公司凭着风险性调节净现值（rNPV）,怎样决策最好买卖构造（订金，里程碑式期支付等？）怎么使用产品估值来决策一个适合的买卖构造?小组合作实践活动阶段外宾来访将会被排序，在获得一个实例时，每一工作组将还有机会来评估一个在设计阶段的 制药业产品。接着向别的工作组展现并相互之间探讨其估值結果 在讨论主题活动时会有下午茶时间16:15 研讨会总结17:00 完毕资询报考请联络 info@lingmed.net / 021-5386 3003，或点一下“阅读”申请注册报考。LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to a full-day workshop on pharma-biotech Product and Company ValuationUnderstand the valuation concepts and techniques that are commonly applied in the pharma and biotech worldKnow how to assess and calculate the value of a biotech companyLearn how to calculate the value of a pharmaceutical in development and how to structure a licensing dealDate:May 5, 2020, Tuesday, 8:30-17:00Location: Marriott Hotel, Shanghai, ChinaFEE:Subscriber: 14,000RMB/personNon-subscriber:15,000RMB/person*Price exclusive of tax*12,000RMB/person for early bird registration before Jan 25, 2020Maximum participants: 20Course BenefitsKnow what determines the value of life science biotechs and emerging pharma companiesGain a thorough understanding of key valuation terms, concepts, tools&techniquesLearn and practice how to:a) Use a model that assesses the soft factors of a biotech company prior to its valuationb) Calculate the value of a development compound with an excel tool you can take home and use for any other pharmaceutical product in developmentc) Structure licensing deals between pharma and biotech, covering issues such as milestones and royalty paymentsGain expert insight and advice from Patrik Frei who has assessed and valued numerous products and companies in the life science industryNetwork and share experiences with BD professionals in ChinaThe Trainer – Patrik FreiPatrik is the Europe's top valuation expert of high-growth life science companies; Patrik is Founder & CEO of venture Valuation AG, specializing in independent assessments and valuation of emerging high-growth companies in biotechnology and the sciences; Patrik and his team carried out all external valuations for the Novartis Venture Fund; Owner of Biotechgate the global life science databaseCourse agenda08:30 Registration & Welcome coffee09:00 Welcome09:15Introduction to Valuation: what –why –whenScope of this courseBasics about valuationThe main drives of valuation : measuring risk vs return10:00How to Assess a Company Prior to ValuationWhy is it important to assess a company before doing a valuationThe three key areas management-technology-marketThe 20 factors required to assess a company10:30 Coffee break10:45Company ValuationInteractive lecture:An overview of approaches for valuing life science companies (e.g. option pricing) and why simple approaches work bestFocus on the most used company valuation methods:a) Discount Cash Flowsb) Venture Capital methodc) Market / Deal comparableValuation in practice - discussion of a historical caseGroup work on a case study：The audience will be broken up in groups. After reading the case, each group has the opportunity to calculate the value of a life science company. The groups will then present and discuss their results in a plenary discussion12:30 Lunch13:45Product Valuation & Deal StructuringInteractive lecture:Difference between company and product valuationWhat information do you need? - How to gather the information?Overview of product valuation methodsIn-depth explanation of the most frequently used technique in Pharma & Biotech:the Risk-adjusted Net Present Value(rNPV)How to calculate the value of a company from several product valuationsGiven an rNPV, how to decide on the best deal structure (upfront payment, milestone payments, royalties and etc?)How to use the product valuation to determine a suitable deal structure?Group work on a case studyThe audience will be broken up in groups.After reading the case, each group has the opportunit
